NCT06592976View on ClinicalTrials.gov

Effects of a Multi-strain Oral Probiotic on the Vaginal Microbiota Composition in Healthy Women and Women with Endometriosis

NAActive, not recruitingINTERVENTIONAL

Enrollment

123

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

May 31, 2025

Conditions

EndometriosisBacterial VaginosisHealthy Volunteer

Interventions

DIETARY_SUPPLEMENT

Multi-strain Oral Probiotic (CDS22-formula)

All patients received the probiotic product CDS22-formula (also known under the tradenames Visbiome, De Simo-ne, Vivomixx) as acid-resistant oral capsules (twice daily for 2 months), containing 1.12 x 10\^11 live bacteria per capsule.

Trial Locations (1)

00185

Umberto I Hospital, University of Rome "Sapienza", Rome

All Listed Sponsors

lead

University of Roma La Sapienza

OTHER